Howe & Rusling’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $312K | Sell |
3,663
-7
| -0.2% | -$624 | 0.02% | 237 |
|
|
2025
Q4 | $290K | Sell |
3,670
-1,232
| -25% | -$96.6K | 0.02% | 243 |
|
|
2025
Q3 | $392K | Buy |
4,902
+1,361
| +38% | +$116K | 0.03% | 199 |
|
|
2025
Q2 | $322K | Buy |
3,541
+1
| +0% | +$91 | 0.02% | 223 |
|
|
2025
Q1 | $332K | Buy |
3,540
+31
| +0.9% | +$2.78K | 0.03% | 202 |
|
|
2024
Q4 | $319K | Sell |
3,509
-55
| -2% | -$5.25K | 0.03% | 207 |
|
|
2024
Q3 | $370K | Buy |
3,564
+24
| +0.7% | +$2.45K | 0.03% | 194 |
|
|
2024
Q2 | $344K | Buy |
3,540
+23
| +0.7% | +$2.12K | 0.03% | 187 |
|
|
2024
Q1 | $317K | Buy |
3,517
+8
| +0.2% | +$678 | 0.03% | 201 |
|
|
2023
Q4 | $280K | Hold |
3,509
| – | – | 0.03% | 196 |
|
|
2023
Q3 | $250K | Sell |
3,509
-70
| -2% | -$5.23K | 0.03% | 196 |
|
|
2023
Q2 | $276K | Hold |
3,579
| – | – | 0.03% | 193 |
|
|
2023
Q1 | $269K | Hold |
3,579
| – | – | 0.03% | 190 |
|
|
2022
Q4 | $282K | Hold |
3,579
| – | – | 0.04% | 174 |
|
|
2022
Q3 | $251K | Sell |
3,579
-10
| -0.3% | -$784 | 0.03% | 183 |
|
|
2022
Q2 | $288K | Buy |
3,589
+1,908
| +114% | +$149K | 0.04% | 163 |
|
|
2022
Q1 | $127K | Hold |
1,681
| – | – | 0.01% | 237 |
|
|
2021
Q4 | $143K | Hold |
1,681
| – | – | 0.02% | 220 |
|
|
2021
Q3 | $127K | Hold |
1,681
| – | – | 0.02% | 226 |
|
|
2021
Q2 | $137K | Hold |
1,681
| – | – | 0.02% | 214 |
|
|
2021
Q1 | $133K | Hold |
1,681
| – | – | 0.02% | 208 |
|
|
2020
Q4 | $144K | Buy |
1,681
+216
| +15% | +$17.9K | 0.02% | 190 |
|
|
2020
Q3 | $113K | Hold |
1,465
| – | – | 0.02% | 197 |
|
|
2020
Q2 | $107K | Hold |
1,465
| – | – | 0.02% | 183 |
|
|
2020
Q1 | $97K | Hold |
1,465
| – | – | 0.02% | 196 |
|
|
2019
Q4 | $101K | Hold |
1,465
| – | – | 0.02% | 234 |
|
|
2019
Q3 | $108K | Hold |
1,465
| – | – | 0.02% | 235 |
|
|
2019
Q2 | $105K | Hold |
1,465
| – | – | 0.02% | 239 |
|
|
2019
Q1 | $100K | Sell |
1,465
-282
| -16% | -$18.2K | 0.02% | 235 |
|
|
2018
Q4 | $104K | Buy |
1,747
+122
| +8% | +$7.63K | 0.02% | 202 |
|
|
2018
Q3 | $109K | Sell |
1,625
-60
| -4% | -$4K | 0.02% | 193 |
|
|
2018
Q2 | $109K | Hold |
1,685
| – | – | 0.02% | 194 |
|
|
2018
Q1 | $121K | Buy |
1,685
+60
| +4% | +$4.32K | 0.02% | 196 |
|
|
2017
Q4 | $123K | Sell |
1,625
-6,003
| -79% | -$438K | 0.02% | 223 |
|
|
2017
Q3 | $556K | Buy |
7,628
+5,935
| +351% | +$428K | 0.1% | 107 |
|
|
2017
Q2 | $126K | Sell |
1,693
-37
| -2% | -$2.75K | 0.03% | 180 |
|
|
2017
Q1 | $127K | Sell |
1,730
-381
| -18% | -$26.7K | 0.03% | 177 |
|
|
2016
Q4 | $138K | Hold |
2,111
| – | – | 0.03% | 172 |
|
|
2016
Q3 | $157K | Buy |
2,111
+381
| +22% | +$28.2K | 0.03% | 158 |
|
|
2016
Q2 | $127K | Sell |
1,730
-200
| -10% | -$14.2K | 0.03% | 167 |
|
|
2016
Q1 | $136K | Hold |
1,930
| – | – | 0.03% | 172 |
|
|
2015
Q4 | $129K | Hold |
1,930
| – | – | 0.03% | 181 |
|
|
2015
Q3 | $122K | Sell |
1,930
-200
| -9% | -$13.1K | 0.03% | 188 |
|
|
2015
Q2 | $139K | Sell |
2,130
-40
| -2% | -$2.71K | 0.03% | 188 |
|
|
2015
Q1 | $150K | Buy |
2,170
+40
| +2% | +$2.77K | 0.03% | 175 |
|
|
2014
Q4 | $147K | Hold |
2,130
| – | – | 0.04% | 169 |
|
|
2014
Q3 | $139K | Buy |
2,130
+400
| +23% | +$26.4K | 0.03% | 172 |
|
|
2014
Q2 | $118K | Sell |
1,730
-640
| -27% | -$42.9K | 0.03% | 199 |
|
|
2014
Q1 | $154K | Buy |
2,370
+340
| +17% | +$21.4K | 0.04% | 168 |
|
|
2013
Q4 | $132K | Hold |
2,030
| – | – | 0.03% | 172 |
|
|
2013
Q3 | $122K | Sell |
2,030
-862
| -30% | -$51.1K | 0.04% | 178 |
|
|
2013
Q2 | $166K | Buy |
+2,892
| New | +$172K | 0.05% | 167 |
|
Other funds holding CL
VCM
DAM
VPM
Howe & Rusling's CL Position: Q1 2026 in Review
Howe & Rusling reduced its Colgate-Palmolive (CL) stake by 0.19% in Q1 2026, selling an estimated $624 and leaving 3,663 shares worth $312K. The position accounts for 0.02% of the portfolio, ranked #237.
Howe & Rusling first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $556K in Q3 2017. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.
- Howe & Rusling held 3,663 shares of Colgate-Palmolive worth $312K as of Q1 2026.
- Howe & Rusling sold 7 Colgate-Palmolive shares in Q1 2026, an estimated $624.
- Colgate-Palmolive made up 0.02% of Howe & Rusling's portfolio in Q1 2026, its #237 holding.
- Howe & Rusling first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
- Howe & Rusling's Colgate-Palmolive position peaked at $556K in Q3 2017.
- 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.
Based on Howe & Rusling's 13F filing for Q1 2026, filed 28 Apr 2026.